NCT04474405 - Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 16, 2013

Primary Completion Date

December 9, 2013

Study Completion Date

December 9, 2013

Conditions

Alzheimer Disease

Interventions

DRUG

Flortaucipir F18

IV injection, 370 MBq (10 mCi), single dose

PROCEDURE

Brain PET Scan

positron emission tomography (PET) scan of the brain starting immediately after administration (60 minute dynamic imaging plus 4 frames x 5 minutes at approximately 80 minutes post-dose).

PROCEDURE

Whole body PET scan

positron emission tomography (PET) scan of the body from the vertex of the head to the thighs starting immediately following injection and repeated over 6 hours

DRUG

Florbetapir F 18

IV injection, 370 MBq (10 mCi), single dose

PROCEDURE

Brain MRI

Volume-based T1-weighted Magnetic Resonance Imaging (MRI) of the brain

Trial Locations (2)

90630

WCCT Global, LLC, Cypress

92658

Hoag Memorial Hospital Presbyterian, Newport Beach